 | • レポートコード：GIR-105X14214 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型ヒト顆粒球コロニー刺激因子のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型ヒト顆粒球コロニー刺激因子の種類別市場規模（レノグラスチム（顆粒球）、フィルグラスチム（ ニューポジェン、ザルツィオ、ニベスティム、レシオグラスチム）、その他）、用途別市場規模（化学療法誘発性好中球減少症、献血前、幹細胞移植、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型ヒト顆粒球コロニー刺激因子の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Qilu Pharmaceutical、Shijiazhuang Pharmaceutical、Kyowa Hakko Kirin、Gensci、Amoytop Biotech、Hangzhou Jiuyuan、Huaxin、Triprime、Sinovac、Zhaoke、Kawin ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：レノグラスチム（顆粒球）、フィルグラスチム（ ニューポジェン、ザルツィオ、ニベスティム、レシオグラスチム）、その他 ・用途別分析2016年-2026年：化学療法誘発性好中球減少症、献血前、幹細胞移植、その他 ・遺伝子組換え型ヒト顆粒球コロニー刺激因子の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型ヒト顆粒球コロニー刺激因子のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型ヒト顆粒球コロニー刺激因子のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型ヒト顆粒球コロニー刺激因子の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型ヒト顆粒球コロニー刺激因子の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Human Granulocyte Colony-Stimulating market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Human Granulocyte Colony-Stimulating size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Human Granulocyte Colony-Stimulating market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Human Granulocyte Colony-Stimulating market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Lenograstim (Granocyte)
Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Others
Market segment by Application can be divided into
Chemotherapy Induced Neutropenia
Before Blood Donation
Stem Cell Transplants
Others
The key market players for global Recombinant Human Granulocyte Colony-Stimulating market are listed below:
Amgen
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Kyowa Hakko Kirin
Gensci
Amoytop Biotech
Hangzhou Jiuyuan
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Human Granulocyte Colony-Stimulating Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Lenograstim (Granocyte)
1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chemotherapy Induced Neutropenia
1.3.3 Before Blood Donation
1.3.4 Stem Cell Transplants
1.3.5 Others
1.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size & Forecast
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value (2016-2026))
1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume (2016-2026)
1.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2026) & (USD/g)
1.5 Global Recombinant Human Granulocyte Colony-Stimulating Production Capacity Analysis
1.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Human Granulocyte Colony-Stimulating Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Human Granulocyte Colony-Stimulating Market Drivers
1.6.2 Recombinant Human Granulocyte Colony-Stimulating Market Restraints
1.6.3 Recombinant Human Granulocyte Colony-Stimulating Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Qilu Pharmaceutical
2.2.1 Qilu Pharmaceutical Details
2.2.2 Qilu Pharmaceutical Major Business
2.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Shijiazhuang Pharmaceutical
2.3.1 Shijiazhuang Pharmaceutical Details
2.3.2 Shijiazhuang Pharmaceutical Major Business
2.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Kyowa Hakko Kirin
2.4.1 Kyowa Hakko Kirin Details
2.4.2 Kyowa Hakko Kirin Major Business
2.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Gensci
2.5.1 Gensci Details
2.5.2 Gensci Major Business
2.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Amoytop Biotech
2.6.1 Amoytop Biotech Details
2.6.2 Amoytop Biotech Major Business
2.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Hangzhou Jiuyuan
2.7.1 Hangzhou Jiuyuan Details
2.7.2 Hangzhou Jiuyuan Major Business
2.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Huaxin
2.8.1 Huaxin Details
2.8.2 Huaxin Major Business
2.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Triprime
2.9.1 Triprime Details
2.9.2 Triprime Major Business
2.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Sinovac
2.10.1 Sinovac Details
2.10.2 Sinovac Major Business
2.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Zhaoke
2.11.1 Zhaoke Details
2.11.2 Zhaoke Major Business
2.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Kawin
2.12.1 Kawin Details
2.12.2 Kawin Major Business
2.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Product and Services
2.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturer
3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Human Granulocyte Colony-Stimulating
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Human Granulocyte Colony-Stimulating Manufacturer Market Share
3.4.2 Top 6 Recombinant Human Granulocyte Colony-Stimulating Manufacturer Market Share
3.5 Global Recombinant Human Granulocyte Colony-Stimulating Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Human Granulocyte Colony-Stimulating Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region
4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2016-2026)
4.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026)
4.3 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026)
4.5 South America Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2016-2026)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2016-2026)
6.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2026)
7.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2026)
7.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
7.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2026)
8.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2026)
8.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
8.3.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2026)
10.2 South America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2026)
10.3 South America Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
10.3.1 South America Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Human Granulocyte Colony-Stimulating Typical Distributors
12.3 Recombinant Human Granulocyte Colony-Stimulating Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 6. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Qilu Pharmaceutical Major Business
Table 9. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 10. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Shijiazhuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Shijiazhuang Pharmaceutical Major Business
Table 13. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 14. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 16. Kyowa Hakko Kirin Major Business
Table 17. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 18. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Gensci Basic Information, Manufacturing Base and Competitors
Table 20. Gensci Major Business
Table 21. Gensci Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 22. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Amoytop Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Amoytop Biotech Major Business
Table 25. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 26. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hangzhou Jiuyuan Basic Information, Manufacturing Base and Competitors
Table 28. Hangzhou Jiuyuan Major Business
Table 29. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 30. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Huaxin Basic Information, Manufacturing Base and Competitors
Table 32. Huaxin Major Business
Table 33. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 34. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Triprime Basic Information, Manufacturing Base and Competitors
Table 36. Triprime Major Business
Table 37. Triprime Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 38. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sinovac Basic Information, Manufacturing Base and Competitors
Table 40. Sinovac Major Business
Table 41. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 42. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Zhaoke Basic Information, Manufacturing Base and Competitors
Table 44. Zhaoke Major Business
Table 45. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 46. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Kawin Basic Information, Manufacturing Base and Competitors
Table 48. Kawin Major Business
Table 49. Kawin Recombinant Human Granulocyte Colony-Stimulating Product and Services
Table 50. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturer (2019-2021e) & (KG)
Table 52. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Recombinant Human Granulocyte Colony-Stimulating, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Recombinant Human Granulocyte Colony-Stimulating Production Capacity by Company, (KG): 2020 VS 2021
Table 55. Head Office and Recombinant Human Granulocyte Colony-Stimulating Production Site of Key Manufacturer
Table 56. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2016-2021e) & (KG)
Table 57. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2021-2026) & (KG)
Table 58. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021e) & (KG)
Table 61. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2021-2026) & (KG)
Table 62. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2021e) & (USD/g)
Table 65. Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2021-2026) & (USD/g)
Table 66. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021e) & (KG)
Table 67. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2021-2026) & (KG)
Table 68. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2021e) & (USD/g)
Table 71. Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2021-2026) & (USD/g)
Table 72. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021e) & (KG)
Table 73. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2021-2026) & (KG)
Table 74. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021e) & (KG)
Table 77. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2021-2026) & (KG)
Table 78. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021e) & (KG)
Table 79. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2021-2026) & (KG)
Table 80. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021e) & (KG)
Table 81. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2021-2026) & (KG)
Table 82. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021e) & (KG)
Table 85. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2021-2026) & (KG)
Table 86. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021e) & (KG)
Table 87. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2021-2026) & (KG)
Table 88. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2016-2021e) & (KG)
Table 89. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2021-2026) & (KG)
Table 90. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021e) & (KG)
Table 93. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2021-2026) & (KG)
Table 94. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021e) & (KG)
Table 95. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2021-2026) & (KG)
Table 96. South America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021e) & (KG)
Table 97. South America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2021-2026) & (KG)
Table 98. South America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021e) & (KG)
Table 101. South America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2021-2026) & (KG)
Table 102. South America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021e) & (KG)
Table 103. South America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2021-2026) & (KG)
Table 104. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021e) & (KG)
Table 105. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2021-2026) & (KG)
Table 106. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021e) & (KG)
Table 109. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2021-2026) & (KG)
Table 110. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021e) & (KG)
Table 111. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2021-2026) & (KG)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Recombinant Human Granulocyte Colony-Stimulating Typical Distributors
Table 115. Recombinant Human Granulocyte Colony-Stimulating Typical Customers
List of Figures
Figure 1. Recombinant Human Granulocyte Colony-Stimulating Picture
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
Figure 3. Lenograstim (Granocyte)
Figure 4. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Figure 5. Others
Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
Figure 7. Chemotherapy Induced Neutropenia
Figure 8. Before Blood Donation
Figure 9. Stem Cell Transplants
Figure 10. Others
Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Recombinant Human Granulocyte Colony-Stimulating Sales (2016-2026) & (KG)
Figure 33. Global Recombinant Human Granulocyte Colony-Stimulating Production Capacity (2016-2026) & (KG)
Figure 34. Global Recombinant Human Granulocyte Colony-Stimulating Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Recombinant Human Granulocyte Colony-Stimulating Market Drivers
Figure 36. Recombinant Human Granulocyte Colony-Stimulating Market Restraints
Figure 37. Recombinant Human Granulocyte Colony-Stimulating Market Trends
Figure 38. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturer in 2020
Figure 39. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturer in 2020
Figure 40. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Recombinant Human Granulocyte Colony-Stimulating Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Recombinant Human Granulocyte Colony-Stimulating Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2026)
Figure 44. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2016-2026)
Figure 45. North America Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026) & (USD Million)
Figure 46. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026) & (USD Million)
Figure 48. South America Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue (2016-2026) & (USD Million)
Figure 50. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2026)
Figure 51. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2016-2026)
Figure 52. Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2026) & (USD/g)
Figure 53. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2026)
Figure 54. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2016-2026)
Figure 55. Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2026) & (USD/g)
Figure 56. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2026)
Figure 57. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2026)
Figure 58. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2026)
Figure 59. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2026)
Figure 60. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2026)
Figure 61. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2026)
Figure 62. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2026)
Figure 63. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2026)
Figure 68. South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2026)
Figure 69. South America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2026)
Figure 70. South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2026)
Figure 71. South America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
ヒト顆粒球コロニー刺激因子の世界市場2018-2025 In 2018, the global Human Granulocyte Colony-stimulating Factor market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Human Gr…- 世界の遺伝子組換え型ヒト卵胞刺激ホルモン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Follitropin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の遺伝子組換え型ヒトトロンボポエチン（rhTPO）市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Thrombopoietin (rhTPO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の遺伝子組換え型ヒトインスリン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- モノクローナル抗体（mAb）バイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…